Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in …

LM Wu, JN Hu, HY Gu, J Hua, J Chen, JR Xu - Breast cancer research and …, 2012 - Springer
Clinical evidence regarding the value of MRI for therapy responses assessment in breast
cancer is increasing. The objective of this study is to compare the diagnostic capability of …

Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer

SH Park, WK Moon, N Cho, IC Song, JM Chang… - Radiology, 2010 - pubs.rsna.org
Purpose To evaluate the potential of diffusion-weighted (DW) magnetic resonance (MR)
imaging with an apparent diffusion coefficient (ADC) map in the prediction of response to …

The diagnostic performance of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in evaluating the pathological response of …

Z Li, J Li, X Lu, M Qu, J Tian, J Lei - European Journal of Radiology, 2021 - Elsevier
Purpose To evaluate and compare the diagnostic performance of diffusion-weighted
imaging (DWI) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in …

Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted magnetic resonance imaging for predicting the response of locally advanced breast …

J Virostko, A Hainline, H Kang… - Journal of Medical …, 2018 - spiedigitallibrary.org
This meta-analysis assesses the prognostic value of quantitative dynamic contrast-
enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted MRI (DW-MRI) …

Diffusion-weighted magnetic resonance imaging of patients with breast cancer following neoadjuvant chemotherapy provides early prediction of pathological …

NP Pereira, C Curi, CABT Osório, EF Marques… - Scientific reports, 2019 - nature.com
The purpose of this study was to evaluate the capacity of diffusion-weighted magnetic
resonance imaging (DW-MRI) for early prediction of pathological response in breast cancer …

Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy

SY Hahn, EY Ko, BK Han, JH Shin, ES Ko - European Journal of Radiology, 2014 - Elsevier
Objective To investigate whether the addition of diffusion-weighted imaging (DWI) to
dynamic contrast-enhanced MRI (DCE-MRI) improves diagnostic performance in predicting …

Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging—comparison with contrast-enhanced MR imaging and …

R Woodhams, S Kakita, H Hata, K Iwabuchi… - Radiology, 2010 - pubs.rsna.org
Purpose To compare the capability of diffusion-weighted (DW) and contrast material–
enhanced magnetic resonance (MR) imaging to provide diagnostic information on residual …

Diffusion-weighted MRI findings predict pathologic response in neoadjuvant treatment of breast cancer: the ACRIN 6698 multicenter trial

SC Partridge, Z Zhang, DC Newitt, JE Gibbs… - Radiology, 2018 - pubs.rsna.org
Purpose To determine if the change in tumor apparent diffusion coefficient (ADC) at diffusion-
weighted (DW) MRI is predictive of pathologic complete response (pCR) to neoadjuvant …

Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapy

CJ Galbán, B Ma, D Malyarenko, MD Pickles, K Heist… - PloS one, 2015 - journals.plos.org
Purpose To evaluate diffusion weighted MRI (DW-MR) as a response metric for assessment
of neoadjuvant chemotherapy (NAC) in patients with primary breast cancer using …

Nomogram for early prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using dynamic contrast-enhanced and diffusion …

R Zhao, H Lu, YB Li, ZZ Shao, WJ Ma, PF Liu - Academic Radiology, 2022 - Elsevier
Rationale and Objectives: The study investigated the potential of the combined use of
dynamic contrast-enhanced MRI and diffusion-weighted imaging in predicting the …